Annexon Biosciences

Vice President, Clinical Development-Ophthalmology

Annexon Biosciences$399K — $427K *
Pharmaceuticals & Biotech
11 - 15 years of experience
Job Overview by Ladders

Qualifications

  • Medical Degree with subspecialty training in Retina; MD or MD/PhD preferred
  • 15-20+ years in pharmaceutical or biotechnology industry focusing on ophthalmology
  • Prior Vice President experience in Clinical Development strongly preferred
  • Proven leadership track record in ophthalmology including commercialization of products
  • In-depth knowledge of ophthalmic diseases, drug development, and regulatory processes
  • Proven strategic planning and execution skills in dynamic environments
  • Strong leadership, communication, and interpersonal skills

Responsibilities

  • Lead medical oversight of Phase 3 programs and communicate with study sites
  • Ensure integrity and quality of clinical documents and regulatory communications
  • Develop life cycle management plan for vonaprument and prepare phase 4 studies
  • Engage with Key Opinion Leaders to advance understanding of vonaprument
  • Design and implement clinical development strategies for successful registration and commercialization
  • Represent Annexon in external engagements with CROs and stakeholders
  • Oversee execution of clinical trials in collaboration with Clinical Operations

Benefits

  • Flexible work schedules and remote opportunities for work-life balance
  • Shuttle service from public transport options
  • Competitive base salary with equity participation and employee stock purchase plan
  • Comprehensive health benefits including medical, dental, and vision coverage
  • 401(k) and flexible spending plans
Full Job Description
Position:

We are seeking an accomplished and visionary leader to join our team as Vice President, Clinical Development-Ophthalmology. The Vice President, Clinical Development-Ophthalmology will play a critical role in shaping and executing our ophthalmology strategy, serve as the clinical leader for Annexon's ophthalmology portfolio, including late-stage programs such as Vonaprument including data readout, interpretation, communication, submission, approval, and commercialization of vonaprument for the treatment of geographic atrophy. This role requires a seasoned professional with deep expertise in ophthalmology, particularly in retinal diseases, and drug development within this therapeutic area, possessing strong leadership skills, and a track record of success in bringing innovative therapies to market. The Vice President, Clinical Development-Ophthalmology will be responsible for driving the clinical strategic direction of our vonaprument franchise working collaboratively with key team leadership. Like all Annexon leaders, the Vice President, Clinical Development-Ophthalmology incumbent will have a deep-rooted commitment to serving patients and a passion for transforming the lives of people with serious diseases and their families.

Responsibilities include:

Drug Development:
  • Lead the medical/clinical oversight of the Phase 3 program including: communication with sites throughout the study in collaboration with the Medical Affairs team, review and interpretation of all clinical data, and communication of results in scientific and informal venues
  • Medical authorship and ensuring the integrity and quality of abstracts, manuscripts, study reports, and regulatory communications and documents, and site or safety (in collaboration with pharmacovigilance) communications
  • Serve as the clinical expert developing the life cycle management plan for vonaprument including an open-label extension study, subset identification, extended dosing, and expanded indications; lead in the preparation of phase 4 clinical studies for these objectives
  • Interactions with Key Opinion Leaders to education and advance the field on the benefit afforded by vonaprument based on its unique mechanism of action
  • Identify core objectives for the design and implementation of the clinical development strategy including an open label extension and, in collaboration with Medical Affairs, Phase 4 clinical studies that support the development, registration, and commercialization of vonaprument
  • Represent Annexon and the vonaprument program for external engagements with CRO's, consultants, sites, etc.
  • In collaboration with Clinical Operations, oversee the execution of clinical trials, ensuring compliance with regulatory requirements, ethical standards, and timelines as well as support for Medical Monitoring activities
  • Serve as the Ophthalmology Lead for the development team, partnering closely with the Program Team Leader, heads of development operations, clinical operations, pharmacovigilance, clinical quality, and biometrics
  • Provide the primary authorship for key clinical sections of marketing authorization submissions (e.g., BLA, MAA, etc.).
  • Provide medical leadership for issue identification/resolution, and data quality
  • Support for business development activities in Ophthalmology

Strategic Leadership:
  • Serve as a member of the vonaprument Core Team and Development Leadership Team to support the creation and execution of a strategic plan for vonaprument, in collaboration with team members, the Program Team Leader, and functional leadership
  • Leverage scientific and clinical expertise to guide decision-making and optimize execution and data interpretation
  • Leadership role in collaboration with Medical Affairs for KOL engagement, Advisory Committee interactions, and Steering Team meetings
  • Drive innovation and differentiation of vonaprument through the deep and complete understanding of current and future data generated for the program
  • In collaboration with Regulatory Affairs and vonaprument Program team, develop and execute robust regulatory strategies for the program
  • Interface with regulatory authorities to facilitate successful regulatory submissions and approvals
  • Stay abreast of evolving guidelines and requirements for ophthalmic drug development

Cross-Functional Collaboration:
  • Foster strong collaboration and alignment across functions, including R&D, clinical development, regulatory affairs, commercial, and other relevant departments.
  • Serve as a key liaison between the ophthalmology team and executive leadership, providing regular updates on portfolio progress and strategic initiatives.
  • Cultivate a culture of teamwork, innovation, and accountability within the ophthalmology organization.

Education, Experience, and Skills:

Required:
  • Medical Degree with subspecialty training and practice in Retina and MD or MD/PhD with deep experience in the field of Ophthalmology required
  • 15 - 20 + years of experience in the pharmaceutical or biotechnology industry, with a focus on ophthalmology drug development
  • Prior experience as a VP in Clinical Development strongly preferred
  • Proven track record of leadership in ophthalmology, including successful development and commercialization of ophthalmology products.
  • In-depth understanding of ophthalmic diseases, drug development processes, and regulatory requirements.
  • Demonstrated ability to develop and execute strategic plans, drive innovation, and deliver results in a fast-paced, dynamic environment.
  • Strong leadership and interpersonal skills, with the ability to inspire and influence teams at all levels of the organization.
  • Excellent communication and presentation skills, with the ability to effectively articulate complex scientific and clinical concepts to diverse audiences.
  • Experience interacting with regulatory authorities and leading successful regulatory submissions and approvals.
  • Business acumen and strategic thinking, with a focus on maximizing the commercial potential of ophthalmology products.

Preferred:
  • Experience with regulatory submissions and clinical trial oversight in a biotech or pharmaceutical setting.
  • Familiarity with emerging trends in ophthalmology, including cutting-edge therapeutic modalities.

Salary Range: $399,600 - $427,500 USD

Location: Annexon Biosciences is located in Brisbane, California and preference is given to candidates in the San Francisco Bay Area.

Benefits:
  • A stimulating and rewarding workplace includes flexible work schedules, remote opportunities and the ability to achieve a work-life balance.
  • Shuttle service from BART, CalTrain and the Ferry.
  • Annexon offers a competitive base salary and equity participation, employee stock purchase plan, as well as a comprehensive health benefit package that includes medical, dental, vision, 401(k), flexible spending plans, and other benefits.

About Annexon Biosciences

Annexon Biosciences is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. The company's pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is advancing a portfolio of product candidates into clinical development, including its lead program, ANX005, for the treatment of Guillain-Barré Syndrome and Warm Autoimmune Hemolytic Anemia. Annexon is deploying a disciplined, biomarker-driven development strategy designed to establish that each of its product candidates is engaging the specific target at a well-tolerated exposure level, enabling the company to continue development with a high level of confidence in its approach.
Learn more about Annexon Biosciences
Size
30 employees
Market Cap
$917
Industry
Founded
2011
NASDAQ

Similar Jobs

More Jobs at Annexon Biosciences

More Pharmaceuticals & Biotech Jobs

Find similar Vice President, Clinical Development-Ophthalmology jobs: